Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Emerging functions of the EGFR in cancer
Sara Sigismund, Daniele Avanzato, Letizia Lanzetti
Molecular Oncology (2017) Vol. 12, Iss. 1, pp. 3-20
Open Access | Times Cited: 1179

Showing 1-25 of 1179 citing articles:

Nanoparticle-Based Drug Delivery in Cancer Therapy and Its Role in Overcoming Drug Resistance
Yihan Yao, Yunxiang Zhou, Lihong Liu, et al.
Frontiers in Molecular Biosciences (2020) Vol. 7
Open Access | Times Cited: 996
Current trends and challenges in cancer management and therapy using designer nanomaterials
P. N. Navya, Anubhav Kaphle, Sangly P. Srinivas, et al.
Nano Convergence (2019) Vol. 6, Iss. 1
Open Access | Times Cited: 577
Cell adhesion in cancer: Beyond the migration of single cells
Michalina Janiszewska, Marina Candido Primi, Tina Izard
Journal of Biological Chemistry (2020) Vol. 295, Iss. 8, pp. 2495-2505
Open Access | Times Cited: 505
Clinical update on head and neck cancer: molecular biology and ongoing challenges
Elham Alsahafi, Katheryn Begg, Ivano Amelio, et al.
Cell Death and Disease (2019) Vol. 10, Iss. 8
Open Access | Times Cited: 438
Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 338
Proteomic analyses of ECM during pancreatic ductal adenocarcinoma progression reveal different contributions by tumor and stromal cells
Chenxi Tian, Karl R. Clauser, Daniel Öhlund, et al.
Proceedings of the National Academy of Sciences (2019) Vol. 116, Iss. 39, pp. 19609-19618
Open Access | Times Cited: 327
Alliance with EPR Effect: Combined Strategies to Improve the EPR Effect in the Tumor Microenvironment
Jooho Park, Yongwhan Choi, Hyeyoun Chang, et al.
Theranostics (2019) Vol. 9, Iss. 26, pp. 8073-8090
Open Access | Times Cited: 289
Proteogenomic insights into the biology and treatment of HPV-negative head and neck squamous cell carcinoma
Chen Huang, Lijun Chen, Sara R. Savage, et al.
Cancer Cell (2021) Vol. 39, Iss. 3, pp. 361-379.e16
Open Access | Times Cited: 273
Advances in covalent kinase inhibitors
Ayah Abdeldayem, Yasir S. Raouf, Stefan N. Constantinescu, et al.
Chemical Society Reviews (2020) Vol. 49, Iss. 9, pp. 2617-2687
Closed Access | Times Cited: 254
Oral squamous cell carcinomas: state of the field and emerging directions
Yunhan Tan, Zhihan Wang, Mengtong Xu, et al.
International Journal of Oral Science (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 243
Regulation of heterogeneous cancer-associated fibroblasts: the molecular pathology of activated signaling pathways
Go J. Yoshida
Journal of Experimental & Clinical Cancer Research (2020) Vol. 39, Iss. 1
Open Access | Times Cited: 220
The Hippo pathway in cancer: YAP/TAZ and TEAD as therapeutic targets in cancer
Richard Cunningham, Carsten Gram Hansen
Clinical Science (2022) Vol. 136, Iss. 3, pp. 197-222
Open Access | Times Cited: 205
Latest developments in metal complexes as anticancer agents
Renata Paprocka, Małgorzata Wiese-Szadkowska, Sabina Janciauskiene, et al.
Coordination Chemistry Reviews (2021) Vol. 452, pp. 214307-214307
Closed Access | Times Cited: 184
Biochemical Aspects of PD-L1 Regulation in Cancer Immunotherapy
Jinfang Zhang, Fabin Dang, Junming Ren, et al.
Trends in Biochemical Sciences (2018) Vol. 43, Iss. 12, pp. 1014-1032
Open Access | Times Cited: 182
Molecular mechanisms of anticancer effect of rutin
Amir Imani, N Dianati Maleki, Sepideh Bohlouli, et al.
Phytotherapy Research (2020) Vol. 35, Iss. 5, pp. 2500-2513
Closed Access | Times Cited: 179
Molecular Targeting Therapy against EGFR Family in Breast Cancer: Progress and Future Potentials
Amaia Eleonora Maennling, Mehmet Kemal Tur, Marcus Niebert, et al.
Cancers (2019) Vol. 11, Iss. 12, pp. 1826-1826
Open Access | Times Cited: 176
EGFR signaling pathway as therapeutic target in human cancers
Elena Levantini, Giorgia Maroni, Marzia Del Re, et al.
Seminars in Cancer Biology (2022) Vol. 85, pp. 253-275
Open Access | Times Cited: 171
Integration of multiomics data with graph convolutional networks to identify new cancer genes and their associated molecular mechanisms
Roman Schulte-Sasse, Stefan Budach, Denes Hnisz, et al.
Nature Machine Intelligence (2021) Vol. 3, Iss. 6, pp. 513-526
Closed Access | Times Cited: 152
Advances in nanomaterial-based targeted drug delivery systems
Xiaoxiao Cheng, Qirong Xie, Yang Sun
Frontiers in Bioengineering and Biotechnology (2023) Vol. 11
Open Access | Times Cited: 143
Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
Karina Biserova, Arvīds Jakovļevs, Romans Uljanovs, et al.
Cells (2021) Vol. 10, Iss. 3, pp. 621-621
Open Access | Times Cited: 141
METTL1‐m7G‐EGFR/EFEMP1 axis promotes the bladder cancer development
Xiaoling Ying, Bixia Liu, Zusen Yuan, et al.
Clinical and Translational Medicine (2021) Vol. 11, Iss. 12
Open Access | Times Cited: 134
Globally Approved EGFR Inhibitors: Insights into Their Syntheses, Target Kinases, Biological Activities, Receptor Interactions, and Metabolism
Mohammed A. S. Abourehab, Alaa M. Alqahtani, Bahaa G. M. Youssif, et al.
Molecules (2021) Vol. 26, Iss. 21, pp. 6677-6677
Open Access | Times Cited: 131
Imidazoles as Potential Anticancer Agents: An Update on Recent Studies
Pankaj Sharma, Chris LaRosa, Janet Antwi, et al.
Molecules (2021) Vol. 26, Iss. 14, pp. 4213-4213
Open Access | Times Cited: 126
Updated Insights on EGFR Signaling Pathways in Glioma
Alexandru Opriţa, Stefania-Carina Baloi, Georgiana-Adeline Staicu, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 2, pp. 587-587
Open Access | Times Cited: 125
Small Molecule EGFR Inhibitors as Anti-Cancer Agents: Discovery, Mechanisms of Action, and Opportunities
Tanzida Zubair, Debasish Bandyopadhyay
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2651-2651
Open Access | Times Cited: 111
Page 1 - Next Page

Scroll to top